ストックスクリーナーアプリを入手
1.057
7.96%
-0.073
前日終値:
$1.13
開ける：
$1.11
24時間の取引高:
32,983
Relative Volume:
0.16
時価総額：
$4.45M
収益：
$10.48M
当期純損益:
$-37.74M
株価収益率:
-0.0653
EPS:
-16.1846
ネットキャッシュフロー:
$-29.03M
1週間 パフォーマンス:
+11.68%
1か月 パフォーマンス:
-3.70%
6か月 パフォーマンス:
-59.06%
1年 パフォーマンス:
-96.47%
1日の値動き範囲:
$1.065
$1.1245
1週間の範囲:
$0.9239
$1.14
52週間の値動き範囲:
$0.9174
$30.12
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
JAGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.065 | 4.72M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.88 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
799.63 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.71 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.19 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.23 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
Jaguar Health reports PS reduction in pediatric intestinal failure study By Investing.com - Investing.com Australia
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication - ACCESS Newswire
Experimental drug lets some children rely less on IV nutrition support - Stock Titan
Knight Therapeutics and Jaguar Health Announce Strategic Partnership - ACCESS Newswire
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Ventura County Star
Jaguar Health (JAGX) Secures $240,000 FDA Grant for Canine Diarr - GuruFocus
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - San Luis Obispo Tribune
FDA backs study of new treatment for chemo-related diarrhea in dogs - Stock Titan
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Norwich Bulletin
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID) - Montgomery Advertiser
Aug Big Picture: Why hedge funds are buying Jaguar Health Inc stock2025 Top Gainers & Community Supported Trade Ideas - moha.gov.vn
Jaguar Health (JAGX) Reports Promising Trials for Crofelemer in UAE - GuruFocus
Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 - Burlington Free Press
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Hillsdale Daily News
What analysts say about Jaguar Health Inc stockPrice Action Analysis & Free Stock Index Interpretations - earlytimes.in
Why Jaguar Health Inc. stock remains on watchlists2025 Short Interest & Entry and Exit Point Strategies - Улправда
Sell Signal: Why Jaguar Health Inc 1JA0 stock benefits from AI revolution2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - moha.gov.vn
Aug PreEarnings: How Jaguar Health Inc. stock reacts to oil prices2025 Investor Takeaways & Target Return Focused Stock Picks - Улправда
Can Jaguar Health Inc. stock deliver surprise earnings beatJuly 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Jaguar Health Earnings Notes - Trefis
How Jaguar Health Inc. stock reacts to oil prices2025 Market WrapUp & Stock Market Timing Techniques - Улправда
Why Jaguar Health Inc. stock could see breakout soonTrade Risk Report & Long-Term Safe Investment Ideas - DonanımHaber
Why analysts recommend Jaguar Health Inc. (1JA0) stockJuly 2025 Retail & Real-Time Volume Analysis Alerts - DonanımHaber
Will Jaguar Health Inc. stock split attract more investorsQuarterly Market Summary & High Return Trade Opportunity Guides - DonanımHaber
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Pensacola News Journal
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF) - Hornell Evening Tribune
Jaguar Health director gets 5,870 RSUs and 5,870 options | JAGX SEC FilingForm 4 - Stock Titan
Jaguar Health submits abstract on crofelemer for short bowel syndrome By Investing.com - Investing.com Canada
Jaguar Health submits abstract on crofelemer for short bowel syndrome - Investing.com India
Jaguar Health (JAGX) Advances Treatment for Short Bowel Syndrome - GuruFocus
Jaguar Health (NASDAQ: JAGX) advances crofelemer program in SBS-IF, MVID trials - Stock Titan
Jaguar Health executes strategic stock exchange agreements - MSN
Jaguar Health Executes Strategic Stock Exchange Agreements - TipRanks
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs - The Florida Times-Union
Jaguar Health Inc (JAGX) is looking forward to a strong quarter - setenews.com
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):